
Mosha-L 4mg/2.5mg Tablet DT
Marketer
Aamorb Pharmaceuticals Pvt Ltd
Salt Composition
Levocetirizine (4mg) + Montelukast (2.5mg)
Overview Mosha-L 4mg/2.5mg Tablet DT
Allergic symptoms like nasal congestion, sneezing, itching, watery eyes, and swelling respond to Mosha-L 4mg/2.5mg Tablet DT, a dual-action medication. This combination therapy also eases airway inflammation, improving breathing. Dosage and duration should follow your physician's instructions; it can be taken with or without food. Treatment duration depends on your response and condition. Premature discontinuation may lead to symptom recurrence and worsening condition. Disclose all other medications to your healthcare provider, as interactions are possible. Common, usually temporary, side effects include nausea, diarrhea, vomiting, dry mouth, headache, rash, flu-like symptoms, and tiredness. Report any concerning side effects immediately. Drowsiness and dizziness are possible; avoid driving or mentally demanding tasks until the effects are known. Alcohol should be avoided due to increased sleepiness risk. Self-medication and recommending this medication to others are strongly discouraged. Adequate hydration is advisable. Kidney disease should be reported to your doctor prior to commencing treatment.
Uses of Mosha-L 4mg/2.5mg Tablet DT
Managing allergic dermatitis | Alleviating allergic rhinitis symptoms | Treating seasonal allergic rhinitis
Major Benefits of Mosha-L 4mg/2.5mg Tablet DT:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Always dissolve the Mosha-L 4mg/2.5mg Tablet DT in water before consumption. While it can be taken with or without food, consistent timing is recommended for optimal results.
Common Side effects of Mosha-L 4mg/2.5mg Tablet DT:
- Nausea
- Diarrhea
- Dryness in mouth
- Fatigue
- Headache
- Skin rash
- Sleepiness
- Vomiting
- Upper respiratory tract infection
- Sore throat
- Fever
- Abdominal pain
- Increased liver enzymes
How to use Mosha-L 4mg/2.5mg Tablet DT:
Administer this medication precisely as your physician directs, both in terms of dosage and treatment length. Dissolve the Mosha-L 4mg/2.5mg Tablet DT in water before ingestion. Consumption may coincide with meals or not, however, consistent timing is recommended.
How Mosha-L 4mg/2.5mg Tablet DT works:
Aller-Ease Duo 4mg/2.5mg tablets combine levocetirizine and montelukast to alleviate allergy symptoms such as sneezing and nasal discharge. Levocetirizine, an antihistamine, counteracts histamine, a substance triggering allergic reactions like rhinorrhea, lacrimation, and sneezing. Montelukast, a leukotriene receptor antagonist, inhibits leukotriene activity, thus diminishing airway and nasal inflammation and improving symptom control.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Mosha-L 4mg/2.5mg Tablet DT concurrently with alcohol. Seek medical advice before combining them.
PregnancySAFE IF PRESCRIBED
The use of Mosha-L 4mg/2.5mg Tablet DT during pregnancy is typically deemed safe. Preclinical trials in animals have revealed minimal or no negative impacts on fetal development; nevertheless, research involving human subjects is currently scarce.
Breast feedingUNSAFE
Administration of Mosha-L 4mg/2.5mg tablets during lactation is contraindicated. Evidence indicates potential infant toxicity.
DrivingUNSAFE
Taking Mosha-L 4mg/2.5mg tablets may cause drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Patients with kidney impairment should use Mosha-L 4mg/2.5mg Tablet DT cautiously, potentially requiring dosage modification. Medical advice is recommended. Mosha-L 4mg/2.5mg Tablet DT is contraindicated in individuals with severe kidney disease.
LiverCAUTION
Patients with severe hepatic impairment should use Mosha-L 4mg/2.5mg Tablet DT cautiously, potentially requiring dosage modification. Consult a physician for guidance. Data regarding Mosha-L 4mg/2.5mg Tablet DT use in such patients is limited. Dosage changes are not advised for individuals with mild or moderate liver disease.
What if you forget to take Mosha-L 4mg/2.5mg Tablet DT :
Should you forget a Mosha-L 4mg/2.5mg Tablet DT dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Mosha-L 4mg/2.5mg Tablet DT
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Medication Classification | Breathing-related |
